Stone Christopher Lewis 4
4 · PDL BIOPHARMA, INC. · Filed Dec 28, 2018
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Tax Payment
Common stock
2018-12-27$3.02/sh−3,581$10,815→ 427,206 total - Disposition to Issuer
Common stock
2018-12-27−228,255→ 198,951 total
Footnotes (1)
- [F1]Disposition of common stock due to performance criteria not being achieved under equity incentive plans.